Clinical trials: Heparin Overdose
Extracorporeal Membrane Oxygenation Complication, Thrombosis
D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD
This was a prospective, cohort study.
- Conditions
- Extracorporeal Membrane Oxygenation Complication, Thrombosis, Hemorrhage, Heparin Overdose
- Trial name
- DIAMOND (NCT03261284)
- Testing
- D-dimer-guided adjustment stratege, Thepeautic-heparin therapy
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Wuhan Asia Heart Hospital
Heparin Overdose of Undetermined Intent, COVID-19
Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients
The majority of ICU patients with COVID-19 show profound activation of coagulation, potentially resulting in thromboembolic events.
- Trial name
- NCT05509647
- Testing
- Unfractionated heparin
- Where
- Netherlands
- Volunteers
- 1,500 people
- Sponsor
- Leiden University Medical Center
Heparin, Heparin Overdose
The Effect of Heparinization Due to LBW
High dose heparin regimens are required in cardiac surgery under cardiopulmonary bypass (CPB) and this may increase postoperative bleeding.
- Conditions
- Heparin, Heparin Overdose, Bleeding
- Trial name
- LBWH (NCT03113708)
- Testing
- Heparin Sodium
- Volunteers
- 50 people
- Sponsor
- Adiyaman University Research Hospital
Aortic Valve Stenosis, Transcatheter Aortic Valve Implantation
HEParin Antagonisation in Transcatheter Aortic Valve Implantation
Unfractioned heparin is usually given in a defined dosage during transfemoral TAVI. Activated Clotting Time (ACT) is usually used to measure the heparin effect.
- Conditions
- Aortic Valve Stenosis, Transcatheter Aortic Valve Implantation, Protamine Sulfate Overdose
- Trial name
- HepaTAVI (NCT05422170)
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- Deutsches Herzzentrum Muenchen